Rivaroxaban population pharmacokinetic and pharmacodynamic modeling in Iranian patients.
What is Known and Objective: Although predictable pharmacokinetic and pharmacodynamic of rivaroxaban allow fixed dosing regimens without routine coagulation monitoring, there is still the necessity to monitor and predict the effects of rivaroxaban in specific conditions and different populations. Th...
| Published in: | Journal of Clinical Pharmacy & Therapeutics Vol. 47; no. 8; pp. 1284 - 1293 |
|---|---|
| Main Authors: | , , , , , |
| Format: | research tables/charts Journal Article |
| Published: |
Wiley-Blackwell
Aug2022
|
| Online Access: | View this record in EBSCOhost |